This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit
Hybrid Event, 20 - 24 June 2022
In-Person: Clayton Hotel Burlington Road, Dublin, IrelandDigital Experience: One track will be live-streamed each day in BST time zone, with on-demand recording access for all other tracks made available from the afternoon of the following day. Learn more on the Digital Experience page.

Megan Doyle
Director, Global Regulatory and R&D Policy at Amgen


Megan Doyle is an attorney and policy professional with nearly 15 years of experience in the regulation of drugs, medical devices, combination products, and in vitro diagnostics.  She received her law degree from Georgetown University Law Center and her master’s degree in public health from Johns Hopkins University.  After seven years in the medical device practice at Hogan Lovells, she joined Amgen as a Senior Counsel for Health Regulatory.  For four years, she counseled Amgen on drug, device, combination product, digital health, and diagnostic matters.  She also advised on the co-development process for teams developing targeted therapies that require a companion diagnostic.  Currently, she is a Director in Amgen’s Global Regulatory and R&D Policy group, where she is the Global Policy Lead for Diagnostics, Digital Health, and Oncology.

Agenda Sessions

  • Industry Panel: First Experiences with IVDR Compliance